Key result
Treatment of community-acquired pneumonia with cefuroxime and doxycycline in a 70-year-old woman on lifelong warfarin resulted in a severe drug interaction, elevating her INR to greater than 15.
Case Report (n=1)
This case highlights the risk of severe warfarin potentiation and supratherapeutic INR when initiating antibiotics such as cefuroxime and doxycycline.
Answers are grounded in this paper and cite their sources.
Clinicians should vigilantly monitor INR with cefuroxime or doxycycline in warfarin patients; this case report leaves open broader interaction risks.
A 70 year old woman was admitted with increasing shortness of breath and feeling generally unwell. The onset of these symptoms had coincided with a mild worsening of her angina. Her medical history included recurrent pulmonary emboli for which she was on lifelong warfarin (15 mg/day, international normalised ratio (INR) stable and therapeutic), an episode of severe pneumonia that necessitated admission to intensive care, and exertional angina for which she used a glyceryl trinitrate spray. She was on no additional medication, and described herself as being “very healthy,” taking great pride in maintaining a nourishing diet rich in fruit and vegetables. On examination the patient was alert and orientated. Respiratory rate was mildly increased, but blood pressure and oxygen saturations were normal. She had right sided bronchial breathing, and plain film radiographs showed right perihilar consolidation. She was treated for community acquired pneumonia with intravenous cefuroxime and oral doxycycline, as per local hospital trust guidelines. Two days after admission the patient showed clinical and subjective improvement. The haematology laboratory then phoned the doctor on call to say that the patient’s INR was greater than 15. There was no evidence of active bleeding. Following advice from a haematologist, the patient was treated with vitamin K. Over the next few days the INR decreased until the patient was deemed fit for discharge. ### 1 What is the mechanism of action of warfarin? #### Short answer Warfarin inhibits the enzyme vitamin K epoxide reductase and thus prevents recycling of oxidised vitamin K. This lowers the amount of reduced vitamin K available, which, in turn, prevents carboxylation and activation of clotting factors dependent on vitamin K …
No takes yet. Share an insight, caveat, or question.
Kidd et al. (2010) conducted a case report in Community acquired pneumonia and warfarin interaction (n=1). Cefuroxime and doxycycline was evaluated on INR elevation. Treatment of community-acquired pneumonia with cefuroxime and doxycycline in a 70-year-old woman on lifelong warfarin resulted in a severe drug interaction, elevating her INR to greater than 15.
Synapse has enriched 10 related papers. Consider them for comparative context: